In the present study, our data indicated that HCC patients with high expression level of UBE2S had shorter disease‐free and overall survival via Kaplan–Meier analyses (p = 0.014 and 0.036, respectively), which indicated that UBE2S in HCC is associated with poor prognosis. This evidence concerns the gene UBE2S and hepatocellular carcinoma.